NCT00430547已完成不适用
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Onset or progression of ophthalmopathy following radio-active iodine therapy
研究概览
简要总结
The purpose of this study is to determine whether radioactive iodine, as compared to anti-thyroid medications, is a risk factor for the development or progression of thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves' disease. The other aim of this study is to determine the incidence of the various ophthalmopathy subtypes and the utility of orbital antibodies in the diagnosis, classification and monitoring of patients with thyroid-associated ophthalmopathy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Graves' disease diagnosed in the last 3 months, regardless of the presence of ophthalmopathy
排除标准
- •Pre-existing eye disease: e.g. orbital surgery, orbital irradiation or significant loss of vision
- •Age < 18 years
- •Inability to consent to participation in the study
- •Pregnancy
- •History of radio-active iodine therapy
结局指标
主要结局
Onset or progression of ophthalmopathy following radio-active iodine therapy
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Quality of Life After Interventional Thyroid TreatmentQuality of LifeDeficiency ThyroidNCT03880578Klinikum Lüdenscheid101
招募中
不适用
Iodine Uptake After a Low Iodine DietDifferentiated Thyroid CancerNCT05599139University Medical Center Groningen25
招募中
不适用
Serum Thyroid Function After Iodinated Contrast AdministrationThyroid DysfunctionNCT05786846Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University400
已完成
1 期
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123Differentiated Thyroid CancerNCT02278198University of Colorado, Denver5
招募中
3 期
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)Thyroid Associated OphthalmopathyNCT06392906Janjira Petsuksiri68